Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-17

Clinical Trial Update: Rhodiola Crenulata as an Adjunctive Therapy in COPD [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2 study evaluating Rhodiola crenulata extract as an adjunctive therapy for COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rhodiola crenulata extract (Rhodiola crenulata extract)

Snippet

Sponsor: Chung Shan Medical University | Conditions: COPD | Phase 2 | Status: COMPLETED